SCHEMBL30007369

SCHEMBL30007369

CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(CN4CCC(c5ccccc5)CC4)c3c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 3/20 0.47
DRD4 P21917 2/20 0.47
DRD3 P35462 2/20 0.47
TNIK Q9UKE5 8/20 0.44
IL2 P60568 1/20 0.42
MAP4K1 Q92918 1/20 0.42
HTR2A P28223 1/20 0.40
SGK1 O00141 2/20 0.39
CAMKK2 Q96RR4 2/20 0.39
MET P08581 1/20 0.38
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
ABL1 P00519 1/20 0.38
INSR P06213 1/20 0.38
CDK2 P24941 1/20 0.38
FLT3 P36888 1/20 0.38
MAP3K11 Q16584 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MMP3 P08254 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007820 0.83 TNIK (0.41) TNIKMAP4K1SGK1METIKBKB
SCHEMBL30007554 0.82 AVPR1A (0.47) IL2MAP4K1SGK1CAMKK2IKBKB
SCHEMBL30007952 0.76 DRD4 (0.59) DRD2DRD4DRD3HTR2AINSR
SCHEMBL30007738 0.75 KDM5A (0.42) ALDH1A1
SCHEMBL30007265 0.72 AVPR1A (0.49) IL2MAP4K1SGK1CAMKK2MAP3K11
Hydrochloric Acid SCHEMBL30007576 0.70 AXL (0.54) SGK1CAMKK2
SCHEMBL30007804 0.69 ALDH1A1 (0.46) TNIKMAP3K11KDM4EALDH1A1
SCHEMBL30007677 0.69 AXL (0.50) SGK1CAMKK2FLT3MAP3K11
SCHEMBL30007672 0.67 PAK1 (0.53) CAMKK2KDM4EALDH1A1
SCHEMBL30008314 0.67 AXL (0.67) SGK1CAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed